Drug Profile
Anthrax vaccine (third generation) - Altimmune
Alternative Names: Lyophilized recombinant protective antigen anthrax vaccine; Lyophilized rPA anthrax vaccine; SparVax-LLatest Information Update: 23 Feb 2021
Price :
$50
*
At a glance
- Originator Avecia
- Developer Altimmune
- Class Anthrax vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Anthrax